3.2600
-0.0200
(-0.61%)
As of 1:08:23 PM GMT+1. Market Open.
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | 0 | 0 | -2.09 | -2.32 |
| Low Estimate | 0 | 0 | -2.09 | -2.32 |
| High Estimate | 0 | 0 | -2.09 | -2.32 |
| Year Ago EPS | -- | -- | -1.61 | -2.09 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 41M | 55M |
| Low Estimate | -- | -- | 41M | 55M |
| High Estimate | -- | -- | 41M | 55M |
| Year Ago Sales | -- | -- | 33.75M | 41M |
| Sales Growth (year/est) | -- | -- | 21.48% | 34.15% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -2.09 | -2.32 |
| 7 Days Ago | 0 | 0 | -1.96 | -2.13 |
| 30 Days Ago | 0 | 0 | -1.96 | -2.13 |
| 60 Days Ago | 0 | 0 | -1.2 | -1.99 |
| 90 Days Ago | 0 | 0 | -1.2 | -1.99 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ABS.OL | -- | -- | -29.91% | -11.00% |
| S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Related Tickers
ELIC.ST Elicera Therapeutics AB (publ)
3.3600
+1.20%
NXTCL.ST NextCell Pharma AB
2.8400
-1.39%
ACE.ST Ascelia Pharma AB (publ)
2.8900
+1.05%
GANX Gain Therapeutics, Inc.
2.2000
+5.26%
ALZN Alzamend Neuro, Inc.
1.1500
+2.68%
APRE Aprea Therapeutics, Inc.
3.8000
+2.43%
ADPT Adaptive Biotechnologies Corporation
7.86
+1.95%
MIST Milestone Pharmaceuticals Inc.
2.0200
+1.00%
UBX Unity Biotechnology, Inc.
2.1400
-4.46%
ELEV Elevation Oncology, Inc.
0.6666
+7.78%